U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Robert F. Kennedy Jr. has pledged to tackle high rates of chronic diseases such as diabetes and obesity as President-elect ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

A new study published in JAMA Psychiatry linked GLP-1 receptor agonists like Ozempic with a lower risk of alcohol-related ...

There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...

Sri Lankans are voting in a parliamentary election that's key for their new, Marxist-leaning president to consolidate his ...

Right now, Viking does not have any treatments that are formally approved by the FDA. Nevertheless, the company's lead obesity candidate, VK2735, has garnered a lot of attention and is widely ...

Supplements promising similar results to Ozempic have taken over social media, but the TGA and health experts have concerns.

Ozempic is making its presence known on menus, and the forecast for dumplings is 100% sunshine.